Liposomal Targeting of Prednisolone Phosphate to Synovial Lining Macrophages during Experimental Arthritis Inhibits M1 Activation but Does Not Favor M2 Differentiation

Documenti analoghi

• Antitumor Activity of Liposomal Prednisolone Phosphate Depends on the Presence of Functional Tumor-Associated Macrophages in Tumor Tissue
  di: Banciu, Manuela, et al.
  Pubblicazione: (2008)
• Liposome-Encapsulated Prednisolone Phosphate Inhibits Growth of Established Tumors in Mice
  di: Schiffelers, Raymond M, et al.
  Pubblicazione: (2005)
• Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis
  di: Metselaar, J, et al.
  Pubblicazione: (2004)
• Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration
  di: van der Valk, Fleur M., et al.
  Pubblicazione: (2015)
• Mesenchymal stem cell therapy in osteoarthritis: advanced tissue repair or intervention with smouldering synovial activation?
  di: van Lent, Peter LEM, et al.
  Pubblicazione: (2013)